Triple

T5248766
Position Surface form Disambiguated ID Type / Status
Subject AstraZeneca E118527 entity
Predicate notableProduct P1448 FINISHED
Object Pulmicort
Pulmicort is a corticosteroid medication (budesonide) commonly used as an inhaled treatment to control and prevent asthma symptoms.
 E506227 NE FINISHED

How this triple was built (4 steps)

Every LLM step that produced this triple, in pipeline order — named-entity classification, the disambiguation choices (the exact options shown, with the pick highlighted), and the generated description. The batch + timestamp of each is in the Provenance table below.

NER Named-entity recognition gpt-5-mini
Instruction
Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).
Input
Phrase: Pulmicort | Statement: [AstraZeneca, notableProduct, Pulmicort]
NED1 Entity disambiguation (via context triple) gpt-5-mini-2025-08-07 
Target entity: Pulmicort
Context triple: [AstraZeneca, notableProduct, Pulmicort]
  • A. Symbicort
    Symbicort is a prescription inhaler medication that combines a corticosteroid and a long-acting bronchodilator to manage asthma and chronic obstructive pulmonary disease (COPD).
  • B. Denesuline
    Denesuline are a First Nations people of the larger Dene cultural and linguistic group, traditionally inhabiting subarctic regions of northern Canada.
  • C. Singulair
    Singulair is a prescription leukotriene receptor antagonist (montelukast) commonly used to prevent and manage asthma and allergy symptoms.
  • D. Synagis
    Synagis is a monoclonal antibody medication used to help prevent serious lower respiratory tract infections caused by respiratory syncytial virus (RSV) in high-risk infants and young children.
  • E. Xolair
    Xolair is a monoclonal antibody medication used to treat moderate to severe allergic asthma and chronic spontaneous urticaria by targeting immunoglobulin E (IgE).
  • F. None of above. chosen
  • G. Unsure - the case is ambiguous/there is not enough information to decide.
NEDg Description generation gpt-5.1
Instruction
Generate a one-sentence description of the target entity. 
You are given a context triple in the form (subject, predicate, object), where the object is the target entity. 
# Instructions
Use the triple to infer relevant information about the entity. Describe the entity based on what is most defining, well-known. 
Avoid repeating the information from the triple, unless really essential.
# Response Format
Return only the sentence: "Description: [one-sentence description of the target entity]"
Input
Entity: Pulmicort
Triple: [AstraZeneca, notableProduct, Pulmicort]
Generated description
Pulmicort is a corticosteroid medication (budesonide) commonly used as an inhaled treatment to control and prevent asthma symptoms.
NED2 Entity disambiguation (via description) gpt-5-mini-2025-08-07 
Target entity: Pulmicort
Target entity description: Pulmicort is a corticosteroid medication (budesonide) commonly used as an inhaled treatment to control and prevent asthma symptoms.
  • A. Symbicort
    Symbicort is a prescription inhaler medication that combines a corticosteroid and a long-acting bronchodilator to manage asthma and chronic obstructive pulmonary disease (COPD).
  • B. Denesuline
    Denesuline are a First Nations people of the larger Dene cultural and linguistic group, traditionally inhabiting subarctic regions of northern Canada.
  • C. Singulair
    Singulair is a prescription leukotriene receptor antagonist (montelukast) commonly used to prevent and manage asthma and allergy symptoms.
  • D. Synagis
    Synagis is a monoclonal antibody medication used to help prevent serious lower respiratory tract infections caused by respiratory syncytial virus (RSV) in high-risk infants and young children.
  • E. Xolair
    Xolair is a monoclonal antibody medication used to treat moderate to severe allergic asthma and chronic spontaneous urticaria by targeting immunoglobulin E (IgE).
  • F. None of above. chosen

Provenance (5 batches)

The batch behind each pipeline step, in order, with when it ran. Timestamps are batch-level — stages were processed in waves, so the object chain (NER → NED1 → NEDg → NED2) reads in order, but predicate / elicitation batches can sit in a different wave.

Step Stage Batch ID Status When
creating Elicitation batch_69bd4468aacc8190a8196f71855cdf4f completed March 20, 2026, 12:58 p.m.
NER Named-entity recognition batch_69bd7b787b34819081af96de9355bb4f completed March 20, 2026, 4:53 p.m.
NED1 Entity disambiguation (via context triple) batch_69befe68e1148190b2e3cc1f9e49dbbf completed March 21, 2026, 8:24 p.m.
NEDg Description generation batch_69beff1e44388190a449cf364f750b8b completed March 21, 2026, 8:27 p.m.
NED2 Entity disambiguation (via description) batch_69beffb133208190a705629dfe6d3bbb completed March 21, 2026, 8:29 p.m.
Created at: March 20, 2026, 1:50 p.m.